Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Advanced Pancreatic Cancer × surufatinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2 Pancreatic Neoplasms 2 Small Cell Lung Carcinoma 1 Pancreatic cancer, adult 1 Osteosarcoma 1 Neoplasms 1 NSCLC 1 Locally Advanced Pancreatic Cancer 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1 Advanced Pancreatic Cancer 1 Adenoma, Islet Cell 1

Interventions

surufatinib 1 nimotuzumab 1 camrelizumab 1 Radiosurgery 1 Injections 1 Drug Therapy 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06329947 2024-05-08

A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD

Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡